V. Sharma, V. Bagrodia, and A. Kulshreshtra, “Enhancing hemophilia A management: emicizumab as a cost-effective adjunct to standard therapy for inhibitor patients”, Int J Basic Clin Pharmacol, vol. 13, no. 3, pp. 395–397, Apr. 2024.